financetom
Business
financetom
/
Business
/
Explained: What are NFTs? A look at India's most popular NFTs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Explained: What are NFTs? A look at India's most popular NFTs
Nov 12, 2021 9:33 AM

Non-fungible tokens (NFTs) are a special type of token that cannot be used to exchange other tokens. This means each NFT has unique characteristics.

NFTs are digital assets that usually represent art, collectible, and in-game items. One can trade in NFTs online. They are generally encoded within smart contracts on a blockchain.

In the world of digitisation, NFTs have opened a new realm of opportunities. They are gradually becoming popular in India. In fact, recently, Bollywood actor Amitabh Bachchan's NFT collections of 'Madhushala', autographed posters and collectibles sold for about Rs 7.18 crore in an auction.

Here's is everything you need to know about NFTs in India

(Edited by : Kanishka Sarkar)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Construction Partners Fiscal Q4 Net Income, Revenue Rise; Annual Sales Outlook Reiterated -- Shares Down Pre-Bell
Construction Partners Fiscal Q4 Net Income, Revenue Rise; Annual Sales Outlook Reiterated -- Shares Down Pre-Bell
Nov 20, 2025
07:37 AM EST, 11/20/2025 (MT Newswires) -- Construction Partners ( ROAD ) reported fiscal Q4 net income Thursday of $1.02 per diluted share, up from $0.56 a year earlier. Analysts polled by FactSet expected $1.10. Revenue for the quarter ended Sept. 30 was $899.8 million, up from $538.2 million a year earlier. Analysts surveyed by FactSet expected $896.1 million. The...
Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences
Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences
Nov 20, 2025
(Reuters) -Abbott said on Thursday it would buy cancer test maker Exact Sciences ( EXAS ) in a deal valued at up to $23 billion, including debt, marking one of its largest acquisitions in nearly a decade and its first major push into cancer screening. The deal will add Exact Sciences' ( EXAS ) flagship colorectal cancer test Cologuard and...
Abbott Laboratories to Acquire Exact Sciences for $21 Billion
Abbott Laboratories to Acquire Exact Sciences for $21 Billion
Nov 20, 2025
07:37 AM EST, 11/20/2025 (MT Newswires) -- Abbott Laboratories ( ABT ) said Thursday it has entered into a definitive agreement to acquire Exact Sciences ( EXAS ) for a total equity value of about $21 billion, or $105 per common share. The deal is expected to close in Q2 of 2026 and is subject to the approval of Exact...
Top Premarket Gainers
Top Premarket Gainers
Nov 20, 2025
07:35 AM EST, 11/20/2025 (MT Newswires) -- PACS Group ( PACS ) shares were 40% higher pre-bell Thursday, a day after the company reported higher Q3 earnings and revenue. Cerence ( CRNC ) stock was up 30% after the company reported late Wednesday improved fiscal Q4 financial results. Magnera ( MAGN ) shares were 20% higher, a day after the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved